Employment outcomes for recent Canadian radiation oncology graduates.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 15 5 2020
Statut: ppublish

Résumé

Radiation oncology (ro) is one of several specialties identified by the Royal College of Physicians and Surgeons of Canada with employment difficulties for graduating trainees. The purpose of the present study was to determine the employment status and location of recent Canadian ro trainees within 2 years after graduation, to monitor workforce recruitment trends over time, and to capture the opinions of program directors about employment difficulty for graduates and resident morale. Visa trainee graduates were excluded. Results of the survey administered to ro program directors in 2016 and again in 2018, both with 100% response rates, are presented here. In both surveys, approximately 57% of ro graduates had attained staff or locum employment in Canada or abroad within 2 years from graduation ( Employment challenges for newly certified Canadian-trained radiation oncologists continue. However, compared with the situation 2 years ago, trends in the Canadian ro job market suggest a modest improvement, with more staff employment in Canada and lower emigration rates for jobs abroad.

Identifiants

pubmed: 31548819
doi: 10.3747/co.26.4925
pii: conc-26-e510
pmc: PMC6726269
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e510-e514

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.

Références

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):876-880
pubmed: 28333001
Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):1017-1021
pubmed: 27302515
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):9-15
pubmed: 28816168
J Med Imaging Radiat Oncol. 2018 Feb;62(1):94-101
pubmed: 29063700
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):969-970
pubmed: 26194674
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1326-31
pubmed: 21640494
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):526-34
pubmed: 15890597
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):539-540
pubmed: 29280447
Radiother Oncol. 2012 Apr;103(1):123-9
pubmed: 22296747
Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):251-6
pubmed: 26238955
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):16-17
pubmed: 30102192
Can Med Educ J. 2012 Mar 31;3(1):e52-63
pubmed: 26451173

Auteurs

S K Loewen (SK)

Division of Radiation Oncology, Tom Baker Cancer Centre, Calgary, AB.

R Halperin (R)

Division of Radiation Oncology, BC Cancer, Kelowna, BC.

G Perry (G)

Department of Radiation Oncology, The Ottawa Hospital, Ottawa, ON.

M McKenzie (M)

Division of Radiation Oncology, BC Cancer, Vancouver, BC.

E Vigneault (E)

Department of Radiation Oncology, chude Québec, Quebec City, QC.

T Stuckless (T)

Department of Radiation Oncology, Dr. H. Bliss Murphy Cancer Centre, St. John's, NL.

M Brundage (M)

Department of Radiation Oncology, Cancer Centre of Southeastern Ontario, Kingston, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH